Overview

Botulinum Toxin A for the Treatment of Keratoconus

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to associate the use of botulinum toxin type A for patients with keratoconus to demonstrate that tension eyelid has an important role in disease progression.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA
Criteria
Inclusion Criteria:

- patients with documented keratoconus

- best-corrected visual acuity measurable at refraction test

- age between 10-40 years

- good health

- understand the procedure and its limitations

Exclusion Criteria:

- only one functional eye

- previous ocular surgery

- concurrent corneal infection and other ocular diseases that modified the visual acuity

- known allergy to botulinum toxin

- pregnancy

- poor collaboration for performing the examinations and the procedure